As the cannabis industry continues its steady growth, one public exchange in Canada has seen a momentum increase in its stocks thanks to favorable policy in the US.

Barrington Miller, director of listed company services for the Canadian Securities Exchange (CSE) credited the approach by the exchange to allow the listing of non licensed producer (LP) cannabis ventures early on the rush for these stocks, he told the Investing News Network (INN).


On Monday (May 28) the exchange hosted a conversation with investors on the cannabis listed companies offering exposure into various markets across the US and Canada on the CSE.

The event included presentations from companies such as Quinsam Capital (CSE:QCA), QuadronCorp (CSE:QCC), and a presentation showcasing an event about upcoming public companies like Ascent Industries, a venture holding licenses to grow cannabis in Canada and the states of Nevada and Oregon.

The CSE was able to share to investors the growth some of its listed cannabis stocks have done such as MPX Bioceutical (CSE:MPX), CannaRoyalty (CSE:CRZ), Beleave (CSE:BE), TerrAscend (CSE:TER) and Liberty Health Sciences (CSE:LHS).

Miller told INN thanks to the positive outlook the US political landscape currently holds for cannabis–despite the drug remaining illegal at a federal level–has impacted the volume of listings on the CSE.

“It seems that the government is addressing the issue and they realize this is not going to be going away and quite frankly there’s a lot of revenue to be made from it and a lot of job opportunities and most importantly quality of life and health and wellness,” he said.

Outlook on US focused CSE listed companies has turned around

During the Lift & Co Expo in Toronto this past weekend, Miller was part of an investing panel where his fellow panelists expressed a bullish sentiment for these CSE stocks, despite earlier in the year opinions were more bearish due to the risks.

John Medland, partner with Blair Franklin Capital Partners said in January he saw more opportunity with CSE US-focused stocks than most experts gave credit to. When asked later by INN why he expressed the risk with these stocks at the time was overblown, he said his expectation was that no crackdowns were coming for these ventures in the US.

“When you look at all those factors I think the American administration is sending some positive signals that the market is reaction to and of course we are feeling it up here in Canada as well,” Miller said.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

New partnerships across exchanges are beneficial for everyone, says CSE official

Over the weekend of May 26-27, MedMen, a popular cannabis operator in California, confirmed its public launch on the CSE market. MedMen has clear intentions in the Canadian market as it developed a partnership with Cronos Group (NASDAQ:CRON; TSX:CRON).

The combined venture will be called MedMen Canada and will focus on the development of branded products and manage retail stores in the country.

CannaRoyalty, also a US operator, inked a deal with National Access Cannabis (TSXV:META) to bring its brands into the planned retail stores the Canadian focused venture will operate once the recreational market comes online across Canada.

On the issue of these new partnerships across Canadian exchanges Miller told INN there are enough opportunities to go around for everyone in the four Canadian public markets.

“If a company is doing business with another company on another exchange that benefits both exchanges,” Miller said.

Pot stocks in Canada have provided boosts to the performance of the major exchanges thanks to the trading activity these see on a regular basis. The CSE Index 25, which tracks the largest companies in the exchange, is regularly topped by the various cannabis listings available to shareholders.

Be sure to check back with @INN_Cannabis for our video interviews and panel recaps from the the Lift & Co. Expo

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Beleave is a client of the Investing News Network. This article is not paid for content.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less